Fine-Scale Haplotype Mapping Reveals an Association of the Gene with Osteoporosis and Fracture Risk in Postmenopausal Women

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2024 Sep 28

PMID 39336743

Authors

Daniela Greere

Sara Haydar

Florin Grigorescu

Dana Manda

Gabriela Voicu

Corinne Lautier

Catalina Poiana

Affiliations

Soon will be listed here.

Abstract

Introduction: The Fat Mass and Obesity-Associated () gene encodes a demethylase, which modulates RNA N6-methyladenosine (m6A) and plays a regulatory role in adipocyte differentiation and the pathogenesis of human obesity.

Methods: To understand the potential role of in osteoporosis (OP), we investigated five single nucleotide variations (SNVs) in intron 1 (rs8057044, rs8050136, rs9939609, rs62033406, and rs9930506) of the gene, and a missense SNV i.e., rs3736228 (A1330V), located in exon 18 of the gene, in a cohort of postmenopausal women ( = 188) from Central Europe. Genotyping was performed with an allele discrimination assay, while haplotypes were reconstructed in the population by PHASE 2.1.

Results: The rs9930506 was strongly associated with OP ( < 0.0035), which was supported by Bonferroni correction ( < 0.0175), and all SNVs located in the gene were more strongly associated with severe OP with fragility fractures. Among seventeen haplotypes detected for the gene, two haplotypes (H1 and H9) were frequent (frequency > 10%) and distributed in three main haplotypes pairs (H1/H1, H1/H9 and H9/H9, respectively). The pathogenic pair H1/H9 was associated with a leaner phenotype, increased fracture risk, and a lower bone mineral density (BMD), and carried the heterozygous GA of rs9930506, while the protective pair H9/H9 was associated with an increased obesity risk and carried AA alleles of rs9939609.

Conclusions: Concordant associations with OP, an increased fracture risk, and a lower BMD at all skeletal sites indicate that the gene is a promising candidate for OP, explaining the complex relationship with obesity and offering new perspectives for the study of the epigenetic regulation of bone metabolism.

References

Attaoua R, Ait El Mkadem S, Radian S, Fica S, Hanzu F, Albu A . FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome. Biochem Biophys Res Commun. 2008; 373(2):230-4. DOI: 10.1016/j.bbrc.2008.06.039. View

Frayling T, Timpson N, Weedon M, Zeggini E, Freathy R, Lindgren C . A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316(5826):889-94. PMC: 2646098. DOI: 10.1126/science.1141634. View

Wang J, Fu Q, Yang J, Liu J, Hou S, Huang X . RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation. Aging (Albany NY). 2021; 13(17):21134-21141. PMC: 8457567. DOI: 10.18632/aging.203377. View

Lautier C, Ait El Mkadem S, Renard E, Brun J, Gris J, Bringer J . Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation. Hum Genet. 2003; 113(1):34-43. DOI: 10.1007/s00439-003-0935-3. View

Gerken T, Girard C, Tung Y, Webby C, Saudek V, Hewitson K . The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007; 318(5855):1469-72. PMC: 2668859. DOI: 10.1126/science.1151710. View

Li Y, Wang J, Huang C, Shen M, Zhan H, Xu K . RNA 6-methyladenosine: a promising molecular target in metabolic diseases. Cell Biosci. 2020; 10:19. PMC: 7035649. DOI: 10.1186/s13578-020-00385-4. View

Grigorie D, Sucaliuc A, Johansson H, Kanis J, McCloskey E . Incidence of hip fracture in Romania and the development of a Romanian FRAX model. Calcif Tissue Int. 2013; 92(5):429-36. DOI: 10.1007/s00223-013-9697-7. View

Barrett J, Fry B, Maller J, Daly M . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2004; 21(2):263-5. DOI: 10.1093/bioinformatics/bth457. View

Liu P, Ilich J, Brummel-Smith K, Ghosh S . New insight into fat, muscle and bone relationship in women: determining the threshold at which body fat assumes negative relationship with bone mineral density. Int J Prev Med. 2014; 5(11):1452-63. PMC: 4274553. View

10.

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

11.

Chen X, Hua W, Huang X, Chen Y, Zhang J, Li G . Regulatory Role of RNA N-Methyladenosine Modification in Bone Biology and Osteoporosis. Front Endocrinol (Lausanne). 2020; 10:911. PMC: 6965011. DOI: 10.3389/fendo.2019.00911. View

12.

De Dios K, Huynh N, Tran T, Center J, Nguyen T . Association between Fat Mass and Obesity-Related Transcript Polymorphisms and Osteoporosis Phenotypes. J Bone Metab. 2024; 31(1):48-55. PMC: 10940110. DOI: 10.11005/jbm.2024.31.1.48. View

13.

Camacho P, Petak S, Binkley N, Diab D, Eldeiry L, Farooki A . AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS- 2020 UPDATE . Endocr Pract. 2020; 26(5):564-570. DOI: 10.4158/GL-2020-0524. View

14.

Vamos A, Arianti R, Vinnai B, Alrifai R, Shaw A, Poliska S . Human abdominal subcutaneous-derived active beige adipocytes carrying rs1421085 obesity-risk alleles exert lower thermogenic capacity. Front Cell Dev Biol. 2023; 11:1155673. PMC: 10321670. DOI: 10.3389/fcell.2023.1155673. View

15.

Rinonapoli G, Pace V, Ruggiero C, Ceccarini P, Bisaccia M, Meccariello L . Obesity and Bone: A Complex Relationship. Int J Mol Sci. 2021; 22(24). PMC: 8706946. DOI: 10.3390/ijms222413662. View

16.

Ben Salem A, Attaoua R, Mtiraoui N, Meddeb S, Kacem O, Ajina M . Haplotyping strategy highlights the specificity of FTO gene association with polycystic ovary syndrome in Tunisian women population. Gene. 2014; 565(2):166-70. DOI: 10.1016/j.gene.2014.12.004. View

17.

Stephens M, Smith N, Donnelly P . A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001; 68(4):978-89. PMC: 1275651. DOI: 10.1086/319501. View

18.

Loos R, Yeo G . The bigger picture of FTO: the first GWAS-identified obesity gene. Nat Rev Endocrinol. 2013; 10(1):51-61. PMC: 4188449. DOI: 10.1038/nrendo.2013.227. View

19.

Tran B, Nguyen N, Center J, Eisman J, Nguyen T . Association between fat-mass-and-obesity-associated (FTO) gene and hip fracture susceptibility. Clin Endocrinol (Oxf). 2013; 81(2):210-7. DOI: 10.1111/cen.12335. View

20.

Greere D, Grigorescu F, Manda D, Lautier C, Poiana C . INSULIN RESISTANCE AND PATHOGENESIS OF POSTMENOPAUSAL OSTEOPOROSIS. Acta Endocrinol (Buchar). 2024; 19(3):349-363. PMC: 10863952. DOI: 10.4183/aeb.2023.349. View